5-132747715-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039780.4(CCNI2):c.220G>T(p.Val74Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,487,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNI2 | NM_001039780.4 | c.220G>T | p.Val74Phe | missense_variant | 1/6 | ENST00000378731.6 | NP_001034869.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNI2 | ENST00000378731.6 | c.220G>T | p.Val74Phe | missense_variant | 1/6 | 1 | NM_001039780.4 | ENSP00000368005.1 | ||
CCNI2 | ENST00000614847.1 | c.220G>T | p.Val74Phe | missense_variant | 1/6 | 1 | ENSP00000478257.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000353 AC: 3AN: 84902Hom.: 0 AF XY: 0.0000415 AC XY: 2AN XY: 48154
GnomAD4 exome AF: 0.000160 AC: 214AN: 1335706Hom.: 0 Cov.: 31 AF XY: 0.000170 AC XY: 112AN XY: 658228
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 28, 2023 | The c.220G>T (p.V74F) alteration is located in exon 1 (coding exon 1) of the CCNI2 gene. This alteration results from a G to T substitution at nucleotide position 220, causing the valine (V) at amino acid position 74 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at